Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Clinician Scientist - Phase 1

University of Toronto

$172,500.00

Identification and Characterization of Human Liver Cancer Stem Cells

FY 2008-09

Summary
Liver cancer is the fifth most common cancer worldwide, and the third most common cause of death from cancer. Some patients with early stage liver cancer can be effectively treated with surgical removal of the tumor or a liver transplant. Most patients have a very poor prognosis because they do not qualify for surgery and other treatments are ineffective. In order to design new treatments to help people with liver cancer, a better understanding is needed of how liver cancer develops. Recent studies suggest that only a few of the cells in a tumor, called "cancer stem cells," are responsible for starting and renewing the tumor as well as determining how it grows, spreads, and responds to therapy. The role of cancer stem cells in liver cancer is not well understood. The first aim of this study is to identify cancer stem cells in human liver cancer. To do this, tumor cells from patients having surgery for liver cancer will be used to grow human liver tumors in mice. Tumor cells with different protein signatures will be tested for their abilities to self-renew as well as generate complete human liver cancers in the mice, which are the hallmarks of cancer stem cells. Once the cancer stem cells can be identified, they will be analyzed for features that are responsible for distinct patterns of tumor growth that are seen in different patients. In addition, the liver cancer stem cells will be compared with mature cells and stem cells from normal liver to better understand how the cancer stem cells develop and function. Finally, the ability to grow human liver tumors in mice will be used to study the effects of different drugs on the ability of liver cancer stem cells to cause disease. This research will provide important new information about the way in which human liver cancer develops, and may lead to new methods to effectively diagnose and treat the many patients with this deadly disease.
Program
CIHR Clinician Scientist - Phase 1
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
173684
Name
Ghanekar Anand
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Clinician Scientist
Projecttitle
Identification and Characterization of Human Liver Cancer Stem Cells
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$172,500
Cihrequipment2
$0
Programname2
CIHR Clinician Scientist - Phase 1
Keyworddelim
Cancer; Differentiation; Flow Cytometry; Hepatocellular Carcinoma; Human; Immunosuppression; Liver; Stem Cell; Transplantation; Xenograft
Abstract
Liver cancer is the fifth most common cancer worldwide, and the third most common cause of death from cancer. Some patients with early stage liver cancer can be effectively treated with surgical removal of the tumor or a liver transplant. Most patients have a very poor prognosis because they do not qualify for surgery and other treatments are ineffective. In order to design new treatments to help people with liver cancer, a better understanding is needed of how liver cancer develops. Recent studies suggest that only a few of the cells in a tumor, called "cancer stem cells," are responsible for starting and renewing the tumor as well as determining how it grows, spreads, and responds to therapy. The role of cancer stem cells in liver cancer is not well understood. The first aim of this study is to identify cancer stem cells in human liver cancer. To do this, tumor cells from patients having surgery for liver cancer will be used to grow human liver tumors in mice. Tumor cells with different protein signatures will be tested for their abilities to self-renew as well as generate complete human liver cancers in the mice, which are the hallmarks of cancer stem cells. Once the cancer stem cells can be identified, they will be analyzed for features that are responsible for distinct patterns of tumor growth that are seen in different patients. In addition, the liver cancer stem cells will be compared with mature cells and stem cells from normal liver to better understand how the cancer stem cells develop and function. Finally, the ability to grow human liver tumors in mice will be used to study the effects of different drugs on the ability of liver cancer stem cells to cause disease. This research will provide important new information about the way in which human liver cancer develops, and may lead to new methods to effectively diagnose and treat the many patients with this deadly disease.
Competitiondate
200809
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ghanekar, Anand
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $172,500~ $0~
University of Toronto - $172,500 Grant (2008-09) | Canada Spends